We investigate the cytokine-producing capacity, activation marker expression and subset distribution of both CD4+ and CD8+ T cells in treatment-naive IPAH patients and after one year of PAH-specific treatment. The gene discussed is CD8A; the disease is pulmonary arterial hypertension.